Reproducibility of pulmonary vein isolation guided by the ablation index: 1-year outcome of the AIR registry

Giuseppe Stabile, Antoine Lepillier, Ermenegildo De Ruvo, Marco Scaglione, Matteo Anselmino, Frederic Sebag, Domenico Pecora, Mark Gallagher, Mariano Rillo, Graziana Viola, Luca Rossi, Valerio De Santis, Maurizio Landolina, Antonello Castro, Massimo Grimaldi, Nicolas Badenco, Maurizio Del Greco, Antonio De Simone, Ennio Pisanò, Salim Abbey, Filippo Lamberti, Antonio Pani, Giulio Zucchelli, Giuseppe Sgarito, Daniela Dugo, Emanuele Bertaglia, Teresa Strisciuglio, Francesco Solimene, Giuseppe Stabile, Antoine Lepillier, Ermenegildo De Ruvo, Marco Scaglione, Matteo Anselmino, Frederic Sebag, Domenico Pecora, Mark Gallagher, Mariano Rillo, Graziana Viola, Luca Rossi, Valerio De Santis, Maurizio Landolina, Antonello Castro, Massimo Grimaldi, Nicolas Badenco, Maurizio Del Greco, Antonio De Simone, Ennio Pisanò, Salim Abbey, Filippo Lamberti, Antonio Pani, Giulio Zucchelli, Giuseppe Sgarito, Daniela Dugo, Emanuele Bertaglia, Teresa Strisciuglio, Francesco Solimene

Abstract

Background: Ablation index (AI) is a new lesion quality marker that has been demonstrated to allow a high single-procedure arrhythmia-free survival in single-center studies. This prospective, multi-center study was designed to evaluate the reproducibility of pulmonary vein (PV) isolation guided by the AI.

Methods: A total of 490 consecutive patients with paroxysmal (80.4%) and persistent AF underwent first time PV isolation and were divided in four study groups according to operator's preference in choosing the ablation catheter (a contact force (ST) or contact force surround flow (STSF) catheter) and the AI setting (330-450 or 380-500 at anterior wall or posterior wall, respectively).

Results: At 12 months a high rate of freedom from AF recurrences was observed in patients with both paroxysmal and persistent AF (91% vs 83.3%; P = .039). There was no difference in the rate of AF recurrence among the four study groups (4.5% in group ST330-450, 12.2% in group ST 380-500, 14.9% in group STSF330-450, 9.4% in group STSF380-500; P = .083). Recurrence was also similar between patients treated with a ST (8%) or STSF catheter (12.1%; P = .2), and within patients targeting an AI settings of 330 to 450 (10.9%) or 380 to 500 (10.3%; P = .64). In patients with paroxysmal AF, there was no difference (P = .12) in the 1-year freedom from AF recurrence among 14 operators that performed ≥10 ablation procedure.

Conclusions: An ablation protocol respecting strict criteria for contiguity and quality lesion resulted in high rate of 1-year freedom from AF recurrence, irrespective of the ablation catheters, AI settings, and operator.

Keywords: ablation index; atrial fibrillation; catheter ablation; reproducibility.

© 2020 Wiley Periodicals LLC.

References

REFERENCES

    1. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018 Jan 1;20(1):e1-e160.
    1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609-1678.
    1. Arbelo E, Brugada J, Blomström-Lundqvist C, et al. on the behalf of the ESC-EHRA atrial fibrillation ablation long-term registry Investigators. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38:1303-1316.
    1. Taghji P, El Haddad M, Phlips T, et al. Evaluation of a strategy aiming to enclose the pulmonary vein with contiguous and optimized radiofrequency lesion in paroxysmal atrial fibrillation. JACC Clin Electrophysiol. 2018;4:99-108.
    1. Hussein A, Das M, Chaturvedi V. Prospective use of ablation index targets improves clinical outcomes following ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28:1037-1047.
    1. Solimene F, Schillaci V, Shopova G, et al. Safety and efficacy of atrial fibrillation ablation guided by ablation index module. J Interv Card Electrophysiol. 2019;54:9-15.
    1. Dhillon G, Ahsan S, Honarbakhsh S, et al. A multicentered evaluation of ablation at higher power guided by ablation index: establishing ablation targets for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2019;30:357-365.
    1. Solimene F, Lepillier A, Ruvo E, et al. Reproducibility of acute pulmonary vein isolation guided by the ablation index. Pacing Clin Electrophysiol. 2019;42:874-881.
    1. Stabile G, Di Donna P, Schillaci V, et al. Safety and efficacy of pulmonary vein isolation using a surround flow catheter with contact force measurement capabilities: a multicenter registry. J Cardiovasc Electrophysiol. 2017;28:762-767.
    1. Zucchelli G, Sirico G, Rebellato L, et al. Contiguity between ablation lesions and strict catheter stability settings assessed by VISITAG TM module improve clinical outcomes of paroxysmal atrial fibrillation ablation-results from the VISITALY study. Circ J. 2018;82:974-982.
    1. Park CI, Lehrmann H, Keyl C, et al. Mechanisms of pulmonary vein reconnection after radiofrequencyablationof atrial fibrillation: the deterministic role of contact force and interlesion distance. J Cardiovasc Electrophysiol. 2014;25:701-708.
    1. Bertaglia E, Stabile G, Senatore G, et al. Predictive value of early atrial fibrillation recurrence after circumferential pulmonary vein ablation. Pace and Clinical Electrophysiology. 2005;28:366-371.
    1. Nery PB, Belliveau D, Nair GM, et al. Relationship between pulmonary vein reconnection and atrial fibrillation recurrence: a systematic review and meta-analysis. J Am Coll Cardiol EP. 2016;2:474-483.
    1. Arbelo E, Brugada J, Lundqvist CB, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38:1303-1316.
    1. De Pooter J, Strisciuglio T, El Haddad M, et al. Pulmonary vein reconnection no longer occurs in the majority of patients after a single pulmonary vein isolation procedure. JACC Clin Electrophysiol. 2019;5:295-305.
    1. Ullah W, Hunter RJ, Finlay MC, et al. Ablation index and surround flow catheter irrigation impedance-based appraisal in clinical ablation. J Am Coll Cardiol EP. 2017;3:1080-1088.
    1. Das M, Loveday JJ, Wynn GJ, et al. Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace. 2017;19:775-783.
    1. El Haddad M, Taghji P, Phlips T, et al. Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation: identifying the weakest link in the ablation chain. Circ Arrhythm Electrophysiol. 2017;10(4):e004867.
    1. Providencia R, Defaye P, Lambiase PD, et al. Results from a multicentre comparison of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible? Europace. 2017;19:48-57.
    1. Landolina M, Arena G, Iacopino S, et al. Center experience does not influence long-term outcome and peri-procedural complications after cryoballoon ablation of paroxysmal atrial fibrillation: data on 860 patients from the real-world multicenter observational project. Int J Cardiol. 2018;272:130-136.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever